EFFECT OF SCREENING OF DONORS FOR ANTIBODIES TO HEPATITIS-C VIRUS BY 2ND-GENERATION ASSAY ON INCIDENCE OF HCV INFECTION IN ACUTE-LEUKEMIA

被引：2

作者：

KAWATANI, T

SUOU, T

ENDO, A

TAJIMA, F

KAWASAKI, H

机构：

[1] The Second Department of Internal Medicine, Tottori University School of Medicine, Yonago, Tottori, 683

来源：

INTERNATIONAL HEPATOLOGY COMMUNICATIONS | 1995年 / 4卷 / 03期

关键词：

HCV; DONOR SCREENING; ACUTE LEUKEMIA;

D O I：

10.1016/0928-4346(95)00235-9

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

We examined the incidence of hepatitis C virus (HCV) infection in 42 patients with acute leukemia before and after blood donor screening for the HCV Ab using the first-generation assay and the second-generation assay. Although 14 (93%) of the 15 patients before screening and 6 (50%) of the 12 patients after screening by the first-generation assay became seropositive for HCV RNA, none of the 15 patients became seropositive after screening by the second-generation assay. These findings indicate that the second-generation assay is effective in preventing HCV infection in multitransfused patients with acute leukemia.

引用

页码：139 / 141

页数：3

共 8 条

[1] THE DECLINING RISK OF POSTTRANSFUSION HEPATITIS-C VIRUS-INFECTION [J].

DONAHUE, JG ;

MUNOZ, A ;

NESS, PM ;

BROWN, DE ;

YAWN, DH ;

MCALLISTER, HA ;

REITZ, BA ;

NELSON, KE .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (06) :369-373

[2]

FAN FS, 1991, BONE MARROW TRANSPL, V8, P417

[3]

FUJII Y, 1994, BONE MARROW TRANSPL, V13, P523

[4]

KAWATANI T, 1993, EUR J HAEMATOL, V51, P254

[5] HEPATITIS-C VIRUS-INFECTION IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].

LOCASCIULLI, A ;

BACIGALUPO, A ;

VANLINT, MT ;

TAGGER, A ;

UDERZO, C ;

PORTMANN, B ;

SHULMAN, HM ;

ALBERTI, A .

TRANSPLANTATION, 1991, 52 (02) :315-318

[6]

LOCASCIULLI A, 1991, BLOOD, V78, P1619

[7]

OKAMOTO H, 1990, JPN J EXP MED, V60, P167

[8]

1991, LANCET, V338, P1040

← 1 →